Crossmark

Brusatol, an NRF2 inhibitor for future cancer therapeutic

Published Online: 2019-06-06

Published Print: 2019-12

Authors

Cai, Sabrina J.

Liu, Yang

Han, Sue

Yang, Chunzhang https://orcid.org/0000-0001-6433-0867
License Information

Text and Data Mining valid from 2019-06-06

Version of Record valid from 2019-06-06
More Information

Article History

Received: 27 May 2019

Accepted: 30 May 2019

First Online: 6 June 2019

Ethics approval and consent to participate

: Not applicable.

: Not applicable.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current